FINKELSTEIN J J

PrivateCIK: 1125610

FINKELSTEIN J J (President and CEO) purchased 4.6% of their position (75K shares) of REGENERX BIOPHARMACEUTICALS INC on the open market

Open‑market purchase worth $15.0K — a small addition. The strongest form of insider conviction signal.

P · 1 purchase
InsiderFINKELSTEIN J JCIK 1125610
→
DirectorOfficer· President and CEO
Since Jul 2018
+187.50K
Net shares
Net buyer
$15.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
187.50K acquired
Non-Derivative Transactions1

Common Stock

Direct
P · Purchase

Shares

+75K

Price / share

$0.20

Trade value

$15K

% of position

4.6%
6/30/2021
1.64M→1.71M
Total

Net shares

+75K

Net value

$15K

Derivative Transactions2

Series A Common Stock Warrant (right to buy)

Direct
P · Purchase
Converts to

Common Stock

56.25K shares

Shares

+56.25K

Strike price

0.24

Held after

56.25K

Exercisable

—

6/30/2021

Series B Common Stock Warrant (right to buy)

Direct
P · Purchase
Converts to

Common Stock

56.25K shares

Shares

+56.25K

Strike price

0.28

Held after

56.25K

Exercisable

—

6/30/2021
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)12

Common Stock Warrant (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

78.13K

Shares owned

78.13K

Exercise price

0.18

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

200K

Shares owned

200K

Exercise price

0.64

Expiration

—

Exercise window

—

Common Stock Warrant (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

20.88K

Shares owned

20.88K

Exercise price

0.45

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

500K

Shares owned

500K

Exercise price

0.30

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

650K

Shares owned

650K

Exercise price

0.21

Expiration

—

Exercise window

—

Convertible Promissory Note (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

104.17K

Shares owned

N/A

Exercise price

0.12

Expiration

—

Exercise window

—

Common Stock Warrant (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

78.13K

Shares owned

78.13K

Exercise price

0.18

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

150K

Shares owned

150K

Exercise price

0.28

Expiration

—

Exercise window

—

Convertible Promissory Note (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

27.84K

Shares owned

N/A

Exercise price

0.36

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

250K

Shares owned

250K

Exercise price

0.21

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

500K

Shares owned

500K

Exercise price

0.36

Expiration

—

Exercise window

—

Convertible Promissory Note (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

104.17K

Shares owned

N/A

Exercise price

0.12

Expiration

—

Exercise window

—

Total

Underlying

2.66M

Owned

2.43M